![](/img/cover-not-exists.png)
Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope ® ): data from the PATRO Adults study
Beck-Peccoz, Paolo, Höybye, Charlotte, Murray, Robert D, Simsek, Suat, Zabransky, Markus, Zouater, Hichem, Stalla, GünterVolume:
11
Journal:
Therapeutic Advances in Endocrinology and Metabolism
DOI:
10.1177/2042018820943377
Date:
January, 2020
File:
PDF, 112 KB
2020